{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:12:07Z","timestamp":1778944327601,"version":"3.51.4"},"publisher-location":"Cham","reference-count":10,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031674570","type":"print"},{"value":"9783031674587","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-67458-7_28","type":"book-chapter","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T05:01:52Z","timestamp":1728882112000},"page":"167-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preventing Fluid Retention After Subarachnoid Haemorrhage During Administration of Endothelin Receptor Antagonist"],"prefix":"10.1007","author":[{"given":"Yu","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Hirahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihide","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"issue":"2","key":"28_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3171\/2015.6.Jns1519","volume":"125","author":"Y Obata","year":"2016","unstructured":"Obata Y, Takeda J, Sato Y, Ishikura H, Matsui T, Isotani E (2016) A multicenter prospective cohort study of volume management after subarachnoid hemorrhage: circulatory characteristics of pulmonary edema after subarachnoid hemorrhage. J Neurosurg 125(2):254\u2013263. https:\/\/doi.org\/10.3171\/2015.6.Jns1519","journal-title":"J Neurosurg"},{"issue":"6","key":"28_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3171\/2022.2.Jns212914","volume":"137","author":"H Endo","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N et al (2022) Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg 137(6):1707\u20131717. https:\/\/doi.org\/10.3171\/2022.2.Jns212914","journal-title":"J Neurosurg"},{"issue":"2","key":"28_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.surneu.2006.10.037","volume":"68","author":"Y Suzuki","year":"2007","unstructured":"Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K (2007) A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol 68(2):126\u2013131.; Discussion 131\u2013122. https:\/\/doi.org\/10.1016\/j.surneu.2006.10.037","journal-title":"Surg Neurol"},{"issue":"2","key":"28_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12028-011-9598-4","volume":"15","author":"N Bruder","year":"2011","unstructured":"Bruder N, Rabinstein A (2011) Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care 15(2):257\u2013269. https:\/\/doi.org\/10.1007\/s12028-011-9598-4","journal-title":"Neurocrit Care"},{"key":"28_CR5","doi-asserted-by":"publisher","unstructured":"Kuwano A, Ishiguro T, Nomura S et al (2023) Predictive factors for improvement of symptomatic cerebral vasospasm following subarachnoid hemorrhage by selective intra-arterial administration of fasudil hydrochloride. Interv Neuroradiol:15910199231155037. https:\/\/doi.org\/10.1177\/15910199231155037","DOI":"10.1177\/15910199231155037"},{"issue":"11","key":"28_CR6","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1161\/strokeaha.108.519942","volume":"39","author":"RL Macdonald","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S et al (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39(11):3015\u20133021. https:\/\/doi.org\/10.1161\/strokeaha.108.519942","journal-title":"Stroke"},{"issue":"6","key":"28_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/strokeaha.111.648980","volume":"43","author":"RL Macdonald","year":"2012","unstructured":"Macdonald RL, Higashida RT, Keller E et al (2012) Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43(6):1463\u20131469. https:\/\/doi.org\/10.1161\/strokeaha.111.648980","journal-title":"Stroke"},{"issue":"2","key":"28_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/0885066617732747","volume":"35","author":"LJM Vergouw","year":"2020","unstructured":"Vergouw LJM, Egal M, Bergmans B et al (2020) High early fluid input after aneurysmal subarachnoid hemorrhage: combined report of association with delayed cerebral ischemia and feasibility of cardiac output-guided fluid restriction. J Intensive Care Med 35(2):161\u2013169. https:\/\/doi.org\/10.1177\/0885066617732747","journal-title":"J Intensive Care Med"},{"issue":"6","key":"28_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs J (2021) Heart failure drug treatment: the fantastic four. Eur Heart J 42(6):681\u2013683. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1012","journal-title":"Eur Heart J"},{"issue":"6","key":"28_CR10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR et al (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke 43(6):1711\u20131737. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839","journal-title":"Stroke"}],"container-title":["Advances in Experimental Medicine and Biology","Oxygen Transport to Tissue XLV"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-67458-7_28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T08:05:00Z","timestamp":1735200300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-67458-7_28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031674570","9783031674587"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-67458-7_28","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"15 October 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"ISOTT","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Society on Oxygen Transport to Tissue","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Tokyo","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Japan","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2023","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16 September 2023","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"30 September 2023","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"isott2023","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}